Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
Conditions
B-cell Malignancy · Non-Hodgkin Lymphoma · Mantle Cell Lymphoma · Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · Waldenström Macroglobulinemia · Marginal Zone Lymphoma · Follicular Lymphoma · DLBCL Unclassifiable · Richter's Transformation
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China
Anhui Provincial Hospital, Hefei, Anhui, China
Peking University Third Hospital, Beijing, Beijing Municipality, China
Beijing Chao Yang Hospital,Capital Medical University, Beijing, Beijing Municipality, China
Second Affiliated Hospital of Army Medical University (Xinqiao Hospital), Chongqing, Chongqing Municipality, China
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Sun Yat Sen University Cancer Center, Guangzhou, Guangdong, China
Guangdong Provincial Peoples Hospital Huifu Branch, Guangzhou, Guangdong, China
The Peoples Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China
Nanyang Central Hospital, Nanyang, Henan, China
Henan Cancer Hospital, Zhengzhou, Henan, China
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Xiangyang Central Hospital, Xiangyang, Hubei, China
The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
Jiangsu Province Hospital, Nanjing, Jiangsu, China
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang, Jiangxi, China
Jiangxi Province Cancer Hospital, Nanchang, Jiangxi, China
The First Hospital of Jilin University, Changchun, Jilin, China
Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China
Shandong Cancer Hospital, Jinan, Shandong, China
Qingdao Central Hospital, Qingdao, Shandong, China
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
Shanxi Provincial Cancer Hospital, Taiyuan, Shanxi, China
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Institute of Hematology and Hospital of Blood Disease, Tianjin, Tianjin Municipality, China
First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
The First Affiliated Hospital, Zhejiang University School of Medicine Branch Yuhang, Hangzhou, Zhejiang, China
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
Study leads
Study Director
BeiGene